Remifentanil for the I-gel and Laryngeal Mask Airway Insertion
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
Structural differences of supraglottic airway devices could influence the different
compressive forces in the oropharyngeal cavities, and require different depth of anesthesia.
The addition of remifentanil during propofol anesthesia facilitates the insertion of
laryngeal mask airway (LMA) with minimal adverse hemodynamic disturbances. This study was
designed to determine the effect-site concentration of remifentanil in 50% of patients (EC50)
and 95% of patients (EC95) for successful i- gel insertion, and compare those for LMA
insertion during propofol target-controlled infusion (TCI).